Search research articles
Contact Us
Filters
Showing results (61-70 of 74) with videos related to
Page
of 8
Sort By:
The Journal of Biological Chemistry
|
January 22, 2013
Drug uptake, lipid rafts, and vesicle trafficking modulate resistance to an anticancer lysophosphatidylcholine analogue in yeast
Álvaro Cuesta-Marbán, Javier Botet, Ola Czyz, et al.
The Journal of Veterinary Medical Science
|
September 15, 2017
Chemical immobilization of free-ranging and captive Sunda clouded leopards (Neofelis diardi) with two anesthetic protocols: medetomidine-ketamine and tiletamine-zolazepam
Fernando Nájera, Andrew J Hearn, Joanna Ross, et al.
Plos One
|
April 7, 2026
Evaluation of medetomidine-tiletamine-zolazepam as a partially reversible field anesthesia combination for mesocarnivores
Fernando Nájera, Jamie L Palmer, Stella F Uiterwaal, et al.
Journal of Cancer Research and Clinical Oncology
|
July 5, 2022
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents
Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Patricia Gómez Martínez-Sagrera, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
January 19, 2026
Economic impact of lung cancer clinical trials: Assessing cost savings in medication and testing
Carolina Pizarro-Gómez, Roberto Collado-Borrell, Vicente Escudero-Vilaplana, et al.
Frontiers in Oncology
|
September 11, 2023
Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy
Elena Ramos-Ruperez, Vicente Escudero-Vilaplana, Paula Ruiz-Briones, et al.
Journal of Chemotherapy (Florence, Italy)
|
March 10, 2026
Real-world evidence for the use of olaparib in pancreatic cancer in Spanish hospitals
Héctor Carlos García-Díaz, Javier Gómez-Alonso, María Teresa Rabuñal-Álvarez, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 28, 2021
Assessment of diarrhea as side effect of oral targeted antineoplastic agents in clinical practice
Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Maria Del Monte-Millán, et al.
Journal of Personalized Medicine
|
August 27, 2021
<i>DPYD</i> Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach
Priscila Villalvazo, Belén Marzal-Alfaro, Pilar García-Alfonso, et al.
Frontiers in Oncology
|
August 8, 2022
Smartphone-Based Ecological Momentary Assessment for the Measurement of the Performance Status and Health-Related Quality of Life in Cancer Patients Under Systemic Anticancer Therapies: Development and Acceptability of a Mobile App
Vicente Escudero-Vilaplana, Lorena Romero-Medrano, Cristina Villanueva-Bueno, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 74) with videos related to
Sort By:
Page
of 8
The Journal of Biological Chemistry
|
January 22, 2013
Drug uptake, lipid rafts, and vesicle trafficking modulate resistance to an anticancer lysophosphatidylcholine analogue in yeast
Álvaro Cuesta-Marbán, Javier Botet, Ola Czyz, et al.
The Journal of Veterinary Medical Science
|
September 15, 2017
Chemical immobilization of free-ranging and captive Sunda clouded leopards (Neofelis diardi) with two anesthetic protocols: medetomidine-ketamine and tiletamine-zolazepam
Fernando Nájera, Andrew J Hearn, Joanna Ross, et al.
Plos One
|
April 7, 2026
Evaluation of medetomidine-tiletamine-zolazepam as a partially reversible field anesthesia combination for mesocarnivores
Fernando Nájera, Jamie L Palmer, Stella F Uiterwaal, et al.
Journal of Cancer Research and Clinical Oncology
|
July 5, 2022
Complementary and alternative medicine in cancer patients: characteristics of use and interactions with antineoplastic agents
Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Patricia Gómez Martínez-Sagrera, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
January 19, 2026
Economic impact of lung cancer clinical trials: Assessing cost savings in medication and testing
Carolina Pizarro-Gómez, Roberto Collado-Borrell, Vicente Escudero-Vilaplana, et al.
Frontiers in Oncology
|
September 11, 2023
Medication guide for dose adjustment and management of cardiotoxicity and lipid metabolic adverse events of oral antineoplastic therapy
Elena Ramos-Ruperez, Vicente Escudero-Vilaplana, Paula Ruiz-Briones, et al.
Journal of Chemotherapy (Florence, Italy)
|
March 10, 2026
Real-world evidence for the use of olaparib in pancreatic cancer in Spanish hospitals
Héctor Carlos García-Díaz, Javier Gómez-Alonso, María Teresa Rabuñal-Álvarez, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
January 28, 2021
Assessment of diarrhea as side effect of oral targeted antineoplastic agents in clinical practice
Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Maria Del Monte-Millán, et al.
Journal of Personalized Medicine
|
August 27, 2021
<i>DPYD</i> Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach
Priscila Villalvazo, Belén Marzal-Alfaro, Pilar García-Alfonso, et al.
Frontiers in Oncology
|
August 8, 2022
Smartphone-Based Ecological Momentary Assessment for the Measurement of the Performance Status and Health-Related Quality of Life in Cancer Patients Under Systemic Anticancer Therapies: Development and Acceptability of a Mobile App
Vicente Escudero-Vilaplana, Lorena Romero-Medrano, Cristina Villanueva-Bueno, et al.
Page
of 8